今日の論文
- Veyrat-Follet, Bruno, et al. (2000) CPT, "Clinical trial simulation of docetaxel in patients with cancer as a tool for dosage optimization"
In current clincal research, clinical trials are often based on guesses of treatment differences taht are not necessarily substantiated and may result in trial failure. Clinical trial simulation is a powerful technology to better assess trial expectation.
-
- モデルの評価について.違いがわかりにくいですけれど,キーワードは 'conditionally' ですね.
To evaluate the models, we simulated the previously defined statistics for time to progression and survival conditionally on actual prognostic factors and cumulative exposure of the phase II patients. To evaluate the simulation process, we simulated the prognostic factors, the dose intensity, and the survival and properly accounted for competing risks.
- Jonsson & Karlsson (2005) Eur J Pharm Sci, "Estimation of dosing strategies aiming at maximizing utility or responder probability, using oxybutynin as an example drug"
- 来ましたね,またこのペア.CPT 2003 の論文("A rational approach for selection of optimal covariate-based dosing strategies")も何が言いたいのかいまだにわからない.